Hep C Experts Condemn Cochrane Review Dissing Direct Antivirals MedPage Today, 27 Jun 2017 When the pharmaceutical company Gilead launched its hepatitis C drug sofosbuvir (Sovaldi) in 2013, it justified the $1,000 per-pi…